Literature DB >> 21397103

The association of comorbid depression with intensive care unit admission in patients with diabetes: a prospective cohort study.

Dimitry S Davydow1, Joan E Russo, Evette Ludman, Paul Ciechanowski, Elizabeth H B Lin, Michael Von Korff, Malia Oliver, Wayne J Katon.   

Abstract

BACKGROUND: It is unknown if comorbid depression in patients with diabetes mellitus increases the risk of intensive care unit (ICU) admission.
OBJECTIVE: This study examined whether comorbid depression in patients with diabetes increased risk of ICU admission, coronary care unit (CCU) admission, and general medical-surgical unit hospitalization, as well as total days hospitalized, after controlling for demographics, clinical characteristics, and health risk behaviors.
METHOD: This prospective cohort study included 3,596 patients with diabetes enrolled in the Pathways Epidemiologic Follow-Up Study. We assessed baseline depression with the Patient Health Questionnaire-9. We controlled for baseline demographics, smoking, BMI, exercise, hemoglobin A(1c), medical comorbidities, diabetes complications, type 1 diabetes, diabetes duration, and insulin treatment. We assessed time to any ICU, CCU, and/or general medical-surgical unit admission using Cox proportional-hazards regression. We used Poisson regression with robust standard errors to examine associations between depression and total days hospitalized.
RESULTS: Unadjusted analyses revealed that baseline probable major depression was associated with increased risk of ICU admission [hazard ratio (HR) 1.94, 95% confidence interval (95% CI)(1.34-2.81)], but was not associated with CCU or general medical-surgical unit admission. Fully adjusted analyses revealed probable major depression remained associated with increased risk of ICU admission [HR 2.23, 95% CI(1.45-3.45)]. Probable major depression was also associated with more total days hospitalized (Incremental Relative Risk 1.64, 95%CI(1.26-2.12)).
CONCLUSIONS: Patients with diabetes and comorbid depression have a greater risk of ICU admission. Improving depression treatment in patients with diabetes could potentially prevent hospitalizations for critical illnesses and lower healthcare costs.
Copyright © 2011 The Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21397103      PMCID: PMC3073638          DOI: 10.1016/j.psym.2010.12.020

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  47 in total

1.  Improving depression care in patients with diabetes and multiple complications.

Authors:  Leslie S Kinder; Wayne J Katon; Evette Ludman; Joan Russo; Greg Simon; Elizabeth H B Lin; Paul Ciechanowski; Michael Von Korff; Bessie Young
Journal:  J Gen Intern Med       Date:  2006-07-07       Impact factor: 5.128

2.  The prevalence of comorbid depression in adults with diabetes: a meta-analysis.

Authors:  R J Anderson; K E Freedland; R E Clouse; P J Lustman
Journal:  Diabetes Care       Date:  2001-06       Impact factor: 19.112

3.  Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure.

Authors:  W Jiang; J Alexander; E Christopher; M Kuchibhatla; L H Gaulden; M S Cuffe; M A Blazing; C Davenport; R M Califf; R R Krishnan; C M O'Connor
Journal:  Arch Intern Med       Date:  2001 Aug 13-27

4.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

5.  Depression and diabetes: impact of depressive symptoms on adherence, function, and costs.

Authors:  P S Ciechanowski; W J Katon; J E Russo
Journal:  Arch Intern Med       Date:  2000-11-27

6.  Ethnic disparities in diabetic complications in an insured population.

Authors:  Andrew J Karter; Assiamira Ferrara; Jennifer Y Liu; Howard H Moffet; Lynn M Ackerson; Joe V Selby
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

7.  Economic costs of diabetes in the US in 2002.

Authors:  Paul Hogan; Tim Dall; Plamen Nikolov
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

8.  Quantifying the risk of infectious diseases for people with diabetes.

Authors:  Baiju R Shah; Janet E Hux
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

9.  Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans.

Authors:  Bessie A Young; Charles Maynard; Gayle Reiber; Edward J Boyko
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

10.  Risk adjustment using automated ambulatory pharmacy data: the RxRisk model.

Authors:  Paul A Fishman; Michael J Goodman; Mark C Hornbrook; Richard T Meenan; Donald J Bachman; Maureen C O'Keeffe Rosetti
Journal:  Med Care       Date:  2003-01       Impact factor: 2.983

View more
  16 in total

1.  Religiously integrated cognitive behavioral therapy: a new method of treatment for major depression in patients with chronic medical illness.

Authors:  Michelle J Pearce; Harold G Koenig; Clive J Robins; Bruce Nelson; Sally F Shaw; Harvey J Cohen; Michael B King
Journal:  Psychotherapy (Chic)       Date:  2014-11-03

2.  Burden of Depressive Symptoms Over 2 Decades and Risk of Nursing Home Placement in Older Women.

Authors:  Amy L Byers; Li-Yung Lui; Eric Vittinghoff; Kenneth E Covinsky; Kristine E Ensrud; Brent Taylor; Kristine Yaffe
Journal:  J Am Geriatr Soc       Date:  2018-08-09       Impact factor: 5.562

Review 3.  Leadership Perspectives on Integrating Psychologists into Specialty Care Clinics: An Evolving Paradigm.

Authors:  Marwan Abouljoud; Michael Ryan; Anne Eshelman; Kelly Bryce; Michelle T Jesse
Journal:  J Clin Psychol Med Settings       Date:  2018-09

4.  Cooccurrence of and remission from general anxiety, depression, and posttraumatic stress disorder symptoms after acute lung injury: a 2-year longitudinal study.

Authors:  O Joseph Bienvenu; Elizabeth Colantuoni; Pedro A Mendez-Tellez; Carl Shanholtz; Cheryl R Dennison-Himmelfarb; Peter J Pronovost; Dale M Needham
Journal:  Crit Care Med       Date:  2015-03       Impact factor: 7.598

5.  The INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) study: Design and methods to address mental healthcare gaps in India.

Authors:  A J Kowalski; S Poongothai; L Chwastiak; M Hutcheson; N Tandon; R Khadgawat; G R Sridhar; S R Aravind; B Sosale; R M Anjana; D Rao; R Sagar; N Mehta; K M V Narayan; J Unutzer; W Katon; V Mohan; M K Ali
Journal:  Contemp Clin Trials       Date:  2017-06-19       Impact factor: 2.226

Review 6.  [Depression and diabetes mellitus type 2].

Authors:  M Deuschle; U Schweiger
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

7.  Health reform and the Affordable Care Act: the importance of mental health treatment to achieving the triple aim.

Authors:  Wayne J Katon; Jürgen Unützer
Journal:  J Psychosom Res       Date:  2013-05-20       Impact factor: 3.006

8.  Input of stakeholders on reducing depressive symptoms and improving diabetes outcomes in India: Formative work for the INDEPENDENT Study.

Authors:  Deepa Rao; Lauren Lipira; Shuba Kumar; Rani Mohanraj; Subramani Poongothai; Nikhil Tandon; G R Sridhar; Wayne Katon; Km Venkat Narayan; Lydia Chwastiak; Viswanathan Mohan; Mohammed K Ali
Journal:  Int J Noncommun Dis       Date:  2016-10-12

9.  Increased Risk of Incident Chronic Kidney Disease, Cardiovascular Disease, and Mortality in Patients With Diabetes With Comorbid Depression.

Authors:  Marta Novak; Istvan Mucsi; Connie M Rhee; Elani Streja; Jun L Lu; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Csaba P Kovesdy
Journal:  Diabetes Care       Date:  2016-06-16       Impact factor: 19.112

10.  Symptoms of depression in survivors of severe sepsis: a prospective cohort study of older Americans.

Authors:  Dimitry S Davydow; Catherine L Hough; Kenneth M Langa; Theodore J Iwashyna
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.